Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
7.46 +0.90 / +13.72%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.46 0.00 / 0.00%
Volume: 25.9K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line10.4M-35.4M-42.6M4.4M
Total Other Cash Flow6.4M6.2M6.3M7.6M
Funds From Operations18.8M-27.9M-35.6M11.6M
Funds From/For Other Operating Expenses422.0K6.7M461.0K-2.2M
Net Cash Flow - Operating Activities18.4M-34.6M-36.1M13.7M
InvestingDecrease In Investments300.0K100.0K1.1M2.4M
Capital Expenditures-226.0K-767.0K-137.0K-714.0K
Fixed Asset Disposal0.00390.0K174.0K143.0K
Net Assets From Acquisitions
Net Cash Flow Investing74.0K-277.0K3.0M1.8M
FinancingShort Term Borrowings0.
Long Term Borrowings0.
Long Term Debt Reduction0.
Net Proceeds Stock Sale3.7M23.7M40.1M37.9M
Common Preferred Redeemed0.
Common Dividends0.
Cash Dividends Paid - Total0.
Other Sources - Financing0.
Other Uses - Financing0.000.0045.0K0.00
Net Cash Flow - Financing3.7M23.7M40.1M37.9M
Exchange RateEffect of Exchange Rate on Cash--
Net Change In Cash22.2M-11.3M7.0M53.4M

To view my watchlist

Not a member yet?

Sign up now for a free account